can i use glp 1 patches while breastfeeding GLP-1 Breastfeeding: Safety & Clinical Guidance – PlexusDx How Long Do You Wear

While this matters less for weekly formulations than it would for daily ones, it still disrupts the predictability of your side effect and appetite suppression patterns

In January 2025, the Food and Drug Administration (FDA) approved a brand of semaglutide to reduce the risk of both cardiovascular death and worsening kidney disease in people with Type 2 diabetes and chronic kidney disease

While these drugs are highly effective for weight loss and glycemic control, they are associated with gastrointestinal issues such as nausea, vomiting, and diarrhea, which can lead to treatment discontinuation among some patients For instance, clinical data and patient reports have shown that adverse events are particularly common during the early stages of treatment with drugs such as semaglutide and tirzepatide, prompting careful dose titration and medical supervision, which may not be feasible for all patients or healthcare settings Addressing these side effect concerns through better patient education, physician training, and next-generation formulations with reduced tolerability issues is crucial to improving long-term adherence and treatment outcomes

Ozempic is typically prescribed in gradually increasing doses to minimize side effects

It is difficult to distinguish symptoms from FDA-approved and compounded products, Basina noted